February 4, 2025 - 03:13

A nurse practitioner has shed light on the advantages of women sleeping without underwear. According to health experts, going commando at night can promote better vaginal health. By allowing the genital area to breathe, women may reduce the risk of yeast infections and other moisture-related issues that can arise from wearing tight-fitting underwear.
Additionally, sleeping without underwear can enhance comfort and promote a more restful night's sleep. The absence of restrictive garments allows for greater freedom of movement, which can be particularly beneficial for those who tend to feel constricted or overheated during the night.
Moreover, this practice can contribute to improved skin health in the intimate area. The lack of friction from underwear may help prevent irritation and chafing, allowing the skin to remain healthy and comfortable. While some may prefer to wear underwear for various reasons, considering the potential benefits of going commando at night could lead to a healthier choice for many women.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...